Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma
Introduction Fractional exhaled nitric oxide is a simple, non-invasive measurement of airway inflammation with minimal discomfort to the patient and with results available within a few minutes. This study aimed to evaluate the cost-effectiveness of asthma management using fractional exhaled nitric o...
- Autores:
-
Buendía, Jefferson Antonio
Acuña-Cordero, Ranniery
Rodriguez-Martinez, Carlos E.
- Tipo de recurso:
- Article of journal
- Fecha de publicación:
- 2021
- Institución:
- Universidad El Bosque
- Repositorio:
- Repositorio U. El Bosque
- Idioma:
- eng
- OAI Identifier:
- oai:repositorio.unbosque.edu.co:20.500.12495/5917
- Palabra clave:
- Health economics
Public health
Healthcare
- Rights
- openAccess
- License
- Atribución 4.0 Internacional
id |
UNBOSQUE2_89bf76daf68288c3eeef8da10f1af007 |
---|---|
oai_identifier_str |
oai:repositorio.unbosque.edu.co:20.500.12495/5917 |
network_acronym_str |
UNBOSQUE2 |
network_name_str |
Repositorio U. El Bosque |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
dc.title.translated.spa.fl_str_mv |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
title |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
spellingShingle |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma Health economics Public health Healthcare |
title_short |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
title_full |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
title_fullStr |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
title_full_unstemmed |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
title_sort |
Cost utility of fractional exhaled nitric oxide monitoring for the management of children asthma |
dc.creator.fl_str_mv |
Buendía, Jefferson Antonio Acuña-Cordero, Ranniery Rodriguez-Martinez, Carlos E. |
dc.contributor.author.none.fl_str_mv |
Buendía, Jefferson Antonio Acuña-Cordero, Ranniery Rodriguez-Martinez, Carlos E. |
dc.subject.keywords.spa.fl_str_mv |
Health economics Public health Healthcare |
topic |
Health economics Public health Healthcare |
description |
Introduction Fractional exhaled nitric oxide is a simple, non-invasive measurement of airway inflammation with minimal discomfort to the patient and with results available within a few minutes. This study aimed to evaluate the cost-effectiveness of asthma management using fractional exhaled nitric oxide monitoring in patients between 4 and 18 years of age. Methods A Markov model was used to estimate the cost-utility of asthma management using fractional exhaled nitric oxide monitoring versus asthma management without using fractional exhaled nitric oxide monitoring (standard therapy) in patients between 4 and 18 years of age. Cost data were obtained from a retrospective study on asthma from a tertiary center, in Medellin, Colombia, while probabilities of the Markov model and utilities were obtained from the systematic review of published randomized clinical trials. The analysis was carried out from a societal perspective. Results The model showed that fractional exhaled nitric oxide monitoring was associated with a lower total cost than standard therapy (US $1333 vs. US $1452 average cost per patient) and higher QALYs (0.93 vs. 0.92 average per patient). The probability that fractional exhaled nitric oxide monitoring provides a more cost-effective use of resources compared with standard therapy exceeds 99% for all willingness-to-pay thresholds. Conclusion Asthma management using fractional exhaled nitric oxide monitoring was cost-effective for treating patients between 4 and 18 years of age with mild to moderate allergic asthma. Our study suggests evidence that could be used by decision-makers to improve clinical practice guidelines, but this should be replicated in different clinical settings. |
publishDate |
2021 |
dc.date.accessioned.none.fl_str_mv |
2021-07-02T14:18:05Z |
dc.date.available.none.fl_str_mv |
2021-07-02T14:18:05Z |
dc.date.issued.none.fl_str_mv |
2021-06-03 |
dc.type.coar.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coarversion.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.local.none.fl_str_mv |
Artículo de revista |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_6501 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
format |
http://purl.org/coar/resource_type/c_6501 |
dc.identifier.issn.none.fl_str_mv |
1478-7547 |
dc.identifier.uri.none.fl_str_mv |
http://hdl.handle.net/20.500.12495/5917 |
dc.identifier.doi.none.fl_str_mv |
https://doi.org/10.1186/s12962-021-00287-3 |
dc.identifier.instname.spa.fl_str_mv |
instname:Universidad El Bosque |
dc.identifier.reponame.spa.fl_str_mv |
reponame:Repositorio Institucional Universidad El Bosque |
dc.identifier.repourl.none.fl_str_mv |
repourl:https://repositorio.unbosque.edu.co |
identifier_str_mv |
1478-7547 instname:Universidad El Bosque reponame:Repositorio Institucional Universidad El Bosque repourl:https://repositorio.unbosque.edu.co |
url |
http://hdl.handle.net/20.500.12495/5917 https://doi.org/10.1186/s12962-021-00287-3 |
dc.language.iso.none.fl_str_mv |
eng |
language |
eng |
dc.relation.ispartofseries.spa.fl_str_mv |
Cost Effectiveness and Resource Allocation, 1478-7547, Vol. 19, No. 01, 2021, art. 33 |
dc.relation.uri.none.fl_str_mv |
https://resource-allocation.biomedcentral.com/articles/10.1186/s12962-021-00287-3 |
dc.rights.*.fl_str_mv |
Atribución 4.0 Internacional |
dc.rights.uri.*.fl_str_mv |
http://creativecommons.org/licenses/by/4.0/ |
dc.rights.local.spa.fl_str_mv |
Acceso abierto |
dc.rights.accessrights.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 info:eu-repo/semantics/openAccess Acceso abierto |
rights_invalid_str_mv |
Atribución 4.0 Internacional http://creativecommons.org/licenses/by/4.0/ Acceso abierto http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.mimetype.none.fl_str_mv |
application/pdf |
dc.publisher.spa.fl_str_mv |
Springer Nature |
dc.publisher.journal.spa.fl_str_mv |
Cost Effectiveness and Resource Allocation |
institution |
Universidad El Bosque |
bitstream.url.fl_str_mv |
https://repositorio.unbosque.edu.co/bitstreams/82bac4ed-9dc8-4366-962a-9f4a294f867c/download https://repositorio.unbosque.edu.co/bitstreams/a2642dfb-98fd-4175-b199-ba67a09a9622/download https://repositorio.unbosque.edu.co/bitstreams/4d757c92-a43b-4ed3-882b-db3ed2e966a7/download https://repositorio.unbosque.edu.co/bitstreams/1acc2c37-4e8a-4b7c-b8d4-7d990e7b97c2/download https://repositorio.unbosque.edu.co/bitstreams/2ef7f5dc-ec09-433c-8346-a1c48d8cf30a/download |
bitstream.checksum.fl_str_mv |
ac80129b0becccacb782cdfcdd69aecf 12c6a182048083f33ade763ef9d2d8fd 0175ea4a2d4caec4bbcc37e300941108 8a4605be74aa9ea9d79846c1fba20a33 768af5c9780ce60c761694abb2ddf90a |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad El Bosque |
repository.mail.fl_str_mv |
bibliotecas@biteca.com |
_version_ |
1814100717889126400 |
spelling |
Buendía, Jefferson AntonioAcuña-Cordero, RannieryRodriguez-Martinez, Carlos E.2021-07-02T14:18:05Z2021-07-02T14:18:05Z2021-06-031478-7547http://hdl.handle.net/20.500.12495/5917https://doi.org/10.1186/s12962-021-00287-3instname:Universidad El Bosquereponame:Repositorio Institucional Universidad El Bosquerepourl:https://repositorio.unbosque.edu.coapplication/pdfengSpringer NatureCost Effectiveness and Resource AllocationCost Effectiveness and Resource Allocation, 1478-7547, Vol. 19, No. 01, 2021, art. 33https://resource-allocation.biomedcentral.com/articles/10.1186/s12962-021-00287-3Atribución 4.0 Internacionalhttp://creativecommons.org/licenses/by/4.0/Acceso abiertohttp://purl.org/coar/access_right/c_abf2info:eu-repo/semantics/openAccessAcceso abiertoCost utility of fractional exhaled nitric oxide monitoring for the management of children asthmaCost utility of fractional exhaled nitric oxide monitoring for the management of children asthmaArtículo de revistahttp://purl.org/coar/resource_type/c_6501http://purl.org/coar/resource_type/c_2df8fbb1info:eu-repo/semantics/articlehttp://purl.org/coar/version/c_970fb48d4fbd8a85Health economicsPublic healthHealthcareIntroduction Fractional exhaled nitric oxide is a simple, non-invasive measurement of airway inflammation with minimal discomfort to the patient and with results available within a few minutes. This study aimed to evaluate the cost-effectiveness of asthma management using fractional exhaled nitric oxide monitoring in patients between 4 and 18 years of age. Methods A Markov model was used to estimate the cost-utility of asthma management using fractional exhaled nitric oxide monitoring versus asthma management without using fractional exhaled nitric oxide monitoring (standard therapy) in patients between 4 and 18 years of age. Cost data were obtained from a retrospective study on asthma from a tertiary center, in Medellin, Colombia, while probabilities of the Markov model and utilities were obtained from the systematic review of published randomized clinical trials. The analysis was carried out from a societal perspective. Results The model showed that fractional exhaled nitric oxide monitoring was associated with a lower total cost than standard therapy (US $1333 vs. US $1452 average cost per patient) and higher QALYs (0.93 vs. 0.92 average per patient). The probability that fractional exhaled nitric oxide monitoring provides a more cost-effective use of resources compared with standard therapy exceeds 99% for all willingness-to-pay thresholds. Conclusion Asthma management using fractional exhaled nitric oxide monitoring was cost-effective for treating patients between 4 and 18 years of age with mild to moderate allergic asthma. Our study suggests evidence that could be used by decision-makers to improve clinical practice guidelines, but this should be replicated in different clinical settings.ORIGINALBuendía_Jefferson_Antonio_2021.pdfBuendía_Jefferson_Antonio_2021.pdfapplication/pdf996519https://repositorio.unbosque.edu.co/bitstreams/82bac4ed-9dc8-4366-962a-9f4a294f867c/downloadac80129b0becccacb782cdfcdd69aecfMD51THUMBNAILBuendía_Jefferson_Antonio_2021.pdf.jpgBuendía_Jefferson_Antonio_2021.pdf.jpgIM Thumbnailimage/jpeg10253https://repositorio.unbosque.edu.co/bitstreams/a2642dfb-98fd-4175-b199-ba67a09a9622/download12c6a182048083f33ade763ef9d2d8fdMD54CC-LICENSElicense_rdflicense_rdfapplication/rdf+xml; charset=utf-8908https://repositorio.unbosque.edu.co/bitstreams/4d757c92-a43b-4ed3-882b-db3ed2e966a7/download0175ea4a2d4caec4bbcc37e300941108MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repositorio.unbosque.edu.co/bitstreams/1acc2c37-4e8a-4b7c-b8d4-7d990e7b97c2/download8a4605be74aa9ea9d79846c1fba20a33MD53TEXTBuendía_Jefferson_Antonio_2021.pdf.txtBuendía_Jefferson_Antonio_2021.pdf.txtExtracted texttext/plain33165https://repositorio.unbosque.edu.co/bitstreams/2ef7f5dc-ec09-433c-8346-a1c48d8cf30a/download768af5c9780ce60c761694abb2ddf90aMD5520.500.12495/5917oai:repositorio.unbosque.edu.co:20.500.12495/59172024-02-06 23:56:34.919http://creativecommons.org/licenses/by/4.0/Atribución 4.0 Internacionalopen.accesshttps://repositorio.unbosque.edu.coRepositorio Institucional Universidad El Bosquebibliotecas@biteca.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 |